Dominic Smethurst, CMO at Bicycle Therapeutics, holds 50.00K shares in Corbus Pharmaceuticals (Ticker: CRBP), holds 36.70K shares in Bicycle Therapeutics (Ticker: BCYC).

See the Hottest Stocks Based on Insider Trading >

Dominic Smethurst
Bicycle Therapeutics (BCYC)
CMO

Ranked #50,000 out of 98,624 Corporate Insiders

Profitable Transactions

1 out of 2 Profitable Transactions

Average Return

-0.70%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

67.24%

CRBP

32.76%

BCYC

A breakdown of Dominic Smethurst's holdings

See the Top Stocks by Insiders

Insider Roles

Corbus Pharmaceuticals
(CRBP)

Chief Medical Officer

Bicycle Therapeutics
(BCYC)

CMO

Roles that Dominic Smethurst holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Bicycle Therapeutics
(BCYC)

Rating:Informative Sell

Date:Jan 05, 2023 - Jan 05, 2024

Return:+45.20%

The most profitable trade made by Dominic Smethurst

See the Latest Stocks Traded by Insiders

Dominic Smethurst's Trading History

BCYC

Bicycle Therapeutics

Jan 05, 2023

CMO

Uninformative Buy

―

$834.17K

CRBP

Corbus Pharmaceuticals

Feb 29, 2024

Chief Medical Officer

Uninformative Buy

―

$1.71M

List of latest transactions for each holding click on a transaction to see Dominic Smethurst's performance on stock

See All Insider Trading from Today

Dominic Smethurst insider profile FAQ

What is the percentage of profitable transactions made by Dominic Smethurst?

The percentage of profitable transactions made by Dominic Smethurst is 50%.

What is the average return per transaction made by Dominic Smethurst?

The average return per transaction made by Dominic Smethurst is -0.70%.

What stocks does Dominic Smethurst hold?

Dominic Smethurst holds: BCYC, CRBP stocks.

What was Dominic Smethurst’s latest transaction?

Dominic Smethurst latest transaction was an Uninformative Buy of ―.

What was Dominic Smethurst's most profitable transaction?

Dominic Smethurst’s most profitable transaction was an Informative Sell of BCYC stock on January 5, 2023. The return on the trade was 45.20%.

What is Dominic Smethurst's role in Bicycle Therapeutics?

Dominic Smethurst's role in Bicycle Therapeutics is CMO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Dominic Smethurst Insider Profile

Dominic Smethurst Bicycle Therapeutics (BCYC)CMO